Tatsis Ourania sold VRTX
February 25, 2025 · Form 4 insider transaction
Tatsis Ourania sold 354 shares of Vertex Pharmaceuticals Incorporated at $480.95 per share, a transaction worth $170.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
354
Price
$480.95
Total value
$170.3K
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2025
Filing dateFebruary 26, 2025
Shares owned after64,031
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.